Overview
- 460 inspections across 358 sites are on record.
- 516 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-07-08.
At a glance
Inspections
460
Sites
358
Observations
516
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Leadiant Biosciences, Inc. | 8 Jul 2021 | Human Drugs | View 483 → |
| SoBran, Inc. | 4 Jun 2021 | Biologics | |
| Roberto Salvatori, M.D. | 13 May 2021 | Human Drugs | View 483 → |
| Ira D. Papel MD | 21 Apr 2021 | Medical Devices & Rad Health | |
| Robert S. Call , M.D. | 25 Mar 2021 | Human Drugs | View 483 → |
Sites inspected
Leadiant Biosciences, Inc.Gaithersburg, United States1 insp.
SoBran, Inc.Falls Church, United States1 insp.
Roberto Salvatori, M.D.Baltimore, United States1 insp.
Ira D. Papel MDPikesville, United States1 insp.
Robert S. Call , M.D.Richmond, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
David L Chon9 shared
Melanie N Daniels7 shared
Robin R Waller5 shared
Cheryl A Grandinetti5 shared
Young M Yoon5 shared
Adriana N Jimenez-Lopez4 shared
David P Rice4 shared
Collins M Mason4 shared
Rina Bhikha4 shared
Earl Echon4 shared
Full investigator report
Get the verbatim findings behind John Dan's 516 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site